A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News EssilorLuxottica wins FDA OK for myopia-slowing eyeglass lensesHealthradar30. September 2025 Dive Brief: The Food and Drug Administration has authorized a spectacle lens from EssilorLuxottica for use in children with nearsightedness.…
